BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 113040
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.113040
Table 3 Postoperative and age group of the study participants, n (%)
Characteristics
65-69 years
70-74 years
75-79 years
80-84 years
85-89 years
χ2 (df)
P value
Gas35.95 (20)0.068
    No0 (0)0 (0)1 (100)0 (0)0 (0)
    Day 121 (45.7)13 (28.3)7 (15.2)3 (6.5)2 (4.3)
    Day 213 (40.6)11 (34.4)5 (15.6)3 (9.4)0 (0)
    Day 34 (44.4)3 (33.3)1 (11.1)0 (0)1 (11.1)
    Day 46 (66.7)1 (11.1)2 (22.2)0 (0)0 (0)
    Day 50 (0)0 (0)0 (0)0 (0)1 (100)
Stool34.23 (28)0.194
    No0 (0)1 (50.0)1 (50.0)0 (0)0 (0)
    Day 113 (39.4)10 (30.3)7 (21.2)1 (3.0)2 (6.1)
    Day 212 (60.0)7 (35.0)1 (5.0)0 (0)0 (0)
    Day 37 (46.7)3 (20.0)4 (26.7)1 (6.7)0 (0)
    Day 44 (50.0)2 (25.0)0 (0)2 (25.0)0 (0)
    Day 54 (40.0)3 (30.0)2 (20.0)1 (10.0)0 (0)
    Day 62 (50.0)1 (25.0)1 (25.0)0 (0)0 (0)
    Day 72 (33.3)1 (16.7)0 (0) 1 (16.7)2 (33.3)
Oral feeding23.27 (16)0.217
    No0 (0)0 (0)1 (100)0 (0)0 (0)
    Day 137 (44.6)24 (28.9)14 (16.9)4 (4.8)4 (4.8)
    Day 26 (50.0)4 (33.3)1 (8.3)1 (8.3)0 (0)
    Day 51 (100)0 (0)0 (0)0 (0)0 (0)
    Day 60 (0)0 (0)0 (0)1 (100)0 (0)
Postop stay (day)9.75 ± 11.269.14 ± 6.5612.31 ± 21.936.17 ± 1.337.00 ± 2.45-0.828
Postop complication16.88 (24)0.775
    Grade 131 (44.3)20 (28.6)11 (15.7)6 (8.6)2 (2.9)
    Grade 24 (57.1)2 (28.6)0 (0)0 (0)1 (14.3)
    Grade 31 (33.3)1 (33.3)1 (33.3)0 (0)0 (0)
    Grade 3a0 (0)1 (100)0 (0)0 (0)0 (0)
    Grade 3b4 (80.0)1 (20.0)0 (0)0 (0)0 (0)
    Grade 4b1 (100)0 (0)0 (0)0 (0)0 (0)
    Grade 53 (27.3)3 (27.3)4 (36.4)0 (0)1 (9.1)
Reoperation3.18 (4)0.535
    No39 (42.9)26 (28.6)16 (17.6)6 (6.6)4 (4.4)
    Yes5 (71.4)2 (28.6)0 (0)0 (0)0 (0)
Adjuvant treatment13.81 (4)0.006
    No9 (29.0)8 (25.8)10 (32.3)1 (3.2)3 (9.7)
    Yes35 (52.2)20 (29.9)6 (9.0)5 (7.5)1 (1.5)
Recurrence4.52 (4)0.358
    No22 (40.0)14 (25.5)11 (20.0)5 (9.1)3 (5.5)
    Yes22 (51.2)14 (32.6)5 (11.6)1 (2.3)1 (2.3)
Follow-up4.81 (4)0.316
    No29 (43.9)16 (24.2)12 (18.2)6 (9.1)3 (4.5)
    Survive15 (46.9)12 (37.5)4 (12.5)0 (0)1 (3.1)


Write to the Help Desk